The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting
Open Access
- 4 February 2024
- journal article
- research article
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 22 (2) , 370-375
Abstract
Seung-Hoon Lee, Kyung Ho Lee, Tae Sun Han, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand, Chi-Un Pae. Clin Psychopharmacol Neurosci 2024;22:370-5. https://doi.org/10.9758/cpn.23.1106Keywords
This publication has 33 references indexed in Scilit:
- The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Anxiety DisordersAnnals of Clinical Psychiatry, 2012
- Aripiprazole as Adjunctive Therapy for Patients with Major Depressive DisorderCNS Drugs, 2011
- Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illnessJournal of Affective Disorders, 2011
- Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.2008
- Aripiprazole in the Treatment of Depressive and Anxiety DisordersCNS Drugs, 2008
- Differential Antidepressant Symptom Efficacy: Placebo-Controlled Comparisons of Duloxetine and SSRIs (Fluoxetine, Paroxetine, Escitalopram)Neuropsychobiology, 2007
- STAR*D: What Have We Learned?American Journal of Psychiatry, 2007
- Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patientsInternational Clinical Psychopharmacology, 2005
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959